SOPHiA GENETICS SA Net Income/Loss 2020-2025 | SOPH
SOPHiA GENETICS SA net income/loss from 2020 to 2025. Net income/loss can be defined as the company's total income or loss before preferred stock dividends, taken from the Income Statement
| SOPHiA GENETICS SA Annual Net Income/Loss (Millions of US $) |
|
|---|---|
| 2024 | $-61 |
| 2023 | $-78 |
| 2022 | $-88 |
| 2021 | $-74 |
| 2020 | $-41 |
| 2019 | $-34 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.192B | $0.065B |
| SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $39.174B | 54.11 |
| Hims & Hers Health (HIMS) | United States | $13.701B | 142.35 |
| Tempus AI (TEM) | United States | $10.751B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.508B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.426B | 69.15 |
| Privia Health (PRVA) | United States | $2.989B | 204.33 |
| Enovis (ENOV) | United States | $1.969B | 10.98 |
| Clover Health Investments (CLOV) | United States | $1.878B | 0.00 |
| Schrodinger (SDGR) | United States | $1.573B | 0.00 |
| Phreesia (PHR) | United States | $1.516B | 0.00 |
| Omnicell (OMCL) | United States | $1.348B | 23.78 |
| Azenta (AZTA) | United States | $1.294B | 60.15 |
| 10x Genomics (TXG) | United States | $1.118B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.646B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.566B | 0.00 |
| Talkspace (TALK) | United States | $0.502B | 150.00 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Claritev (CTEV) | United States | $0.472B | 0.00 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| TruBridge (TBRG) | United States | $0.374B | 830.67 |
| Health Catalyst (HCAT) | United States | $0.274B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.262B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.144B | 0.00 |
| Pulmonx (LUNG) | United States | $0.135B | 0.00 |
| American Well (AMWL) | United States | $0.118B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.102B | 0.00 |
| CareCloud (CCLD) | United States | $0.090B | 3.42 |
| Outset Medical (OM) | United States | $0.070B | 0.00 |
| 111 (YI) | China | $0.069B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.058B | 0.00 |
| HeartBeam (BEAT) | United States | $0.056B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.031B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Precipio (PRPO) | United States | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |